Free Trial

Tandem Investment Partners LLC Buys Shares of 3,015 Danaher Co. (NYSE:DHR)

Danaher logo with Medical background
Remove Ads

Tandem Investment Partners LLC bought a new stake in Danaher Co. (NYSE:DHR - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 3,015 shares of the conglomerate's stock, valued at approximately $692,000.

Several other institutional investors also recently made changes to their positions in DHR. Heck Capital Advisors LLC acquired a new position in Danaher during the 4th quarter valued at approximately $27,000. Decker Retirement Planning Inc. bought a new stake in Danaher in the fourth quarter valued at $31,000. Golden State Wealth Management LLC acquired a new position in shares of Danaher during the fourth quarter valued at $31,000. Strategic Financial Concepts LLC bought a new position in shares of Danaher during the fourth quarter worth about $31,000. Finally, Pineridge Advisors LLC increased its holdings in shares of Danaher by 63.3% in the 4th quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate's stock worth $34,000 after acquiring an additional 57 shares during the period. 79.05% of the stock is owned by institutional investors.

Analysts Set New Price Targets

DHR has been the subject of a number of analyst reports. Guggenheim began coverage on shares of Danaher in a research note on Thursday, December 19th. They set a "buy" rating and a $275.00 target price for the company. Citigroup reiterated a "buy" rating on shares of Danaher in a research report on Monday, April 7th. Robert W. Baird lowered their target price on Danaher from $277.00 to $268.00 and set an "overweight" rating on the stock in a research report on Tuesday, January 28th. Wells Fargo & Company reduced their price target on Danaher from $280.00 to $240.00 and set an "equal weight" rating for the company in a research report on Thursday, January 30th. Finally, Stifel Nicolaus raised Danaher from a "hold" rating to a "buy" rating and set a $260.00 price target on the stock in a report on Friday, March 14th. Four research analysts have rated the stock with a hold rating and eighteen have given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $276.57.

Remove Ads

Get Our Latest Stock Report on DHR

Insider Transactions at Danaher

In related news, SVP Brian W. Ellis sold 5,700 shares of the firm's stock in a transaction that occurred on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the transaction, the senior vice president now owns 20,230 shares of the company's stock, valued at approximately $4,534,149.90. This trade represents a 21.98 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 11.10% of the stock is currently owned by insiders.

Danaher Price Performance

Shares of NYSE DHR traded up $7.99 during trading on Friday, hitting $188.75. The company had a trading volume of 4,764,014 shares, compared to its average volume of 3,316,814. Danaher Co. has a 52 week low of $171.00 and a 52 week high of $281.70. The business's 50-day moving average is $203.71 and its 200 day moving average is $229.91. The company has a market cap of $134.90 billion, a P/E ratio of 35.75, a PEG ratio of 2.66 and a beta of 0.86. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40.

Danaher (NYSE:DHR - Get Free Report) last announced its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same quarter last year, the firm earned $2.09 EPS. Equities research analysts predict that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be issued a $0.32 dividend. This represents a $1.28 annualized dividend and a dividend yield of 0.68%. This is a boost from Danaher's previous quarterly dividend of $0.27. The ex-dividend date is Friday, March 28th. Danaher's dividend payout ratio (DPR) is presently 24.24%.

Danaher Profile

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Recommended Stories

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Should You Invest $1,000 in Danaher Right Now?

Before you consider Danaher, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.

While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Donald Trump Owns These 7 Stocks, Should You?

Donald Trump Owns These 7 Stocks, Should You?

He’s one of the most talked-about billionaires in the world—but when it comes to investing, Donald Trump’s stock picks are shockingly… low-key.

Related Videos

Donald Trump Owns These 7 Stocks, Should You?
Quantum Stocks Are Heating Up Again — 7 to Watch Now
Quantum Stocks Are Heating Up Again — 7 to Watch Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads